Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-09
DOI
10.3389/fimmu.2022.832645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-driving armored CAR-T cells overcome suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models
- (2021) Brian Webster et al. MOLECULAR THERAPY
- Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
- (2020) Estefanía García-Guerrero et al. Frontiers in Immunology
- BCMA-targeted immunotherapy for multiple myeloma
- (2020) Bo Yu et al. Journal of Hematology & Oncology
- Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic health record data
- (2020) Megan Braunlin et al. LEUKEMIA & LYMPHOMA
- Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity
- (2020) Vivian Weiwen Xue et al. Cancers
- Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
- (2020) You Li et al. Frontiers in Oncology
- B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
- (2019) Adam D. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- (2019) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- TGFβ inhibition stimulates collagen maturation to enhance bone repair and fracture resistance in a murine myeloma model
- (2019) Alanna C Green et al. JOURNAL OF BONE AND MINERAL RESEARCH
- B cell maturation antigen‐specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta‐analysis
- (2019) Nico Gagelmann et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells associate with clinical outcomes in NHL
- (2018) John Rossi et al. BLOOD
- Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
- (2018) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
- (2018) Jennifer N. Brudno et al. JOURNAL OF CLINICAL ONCOLOGY
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
- (2018) Wan-Hong Zhao et al. Journal of Hematology & Oncology
- MM-BMSCs induce naïve CD4+ T lymphocytes dysfunction through fibroblast activation protein α
- (2017) Xiaofei Wu et al. Oncotarget
- T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
- (2016) S. A. Ali et al. BLOOD
- Upregulation of CD200 is associated with regulatory T cell expansion and disease progression in multiple myeloma
- (2015) Salah Aref et al. HEMATOLOGICAL ONCOLOGY
- Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities
- (2015) G. Shay et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
- (2014) Tom Luedde et al. GASTROENTEROLOGY
- Bone Marrow Microenvironment in Multiple Myeloma Progression
- (2012) S. Manier et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- SPICE: Exploration and analysis of post-cytometric complex multivariate datasets
- (2011) Mario Roederer et al. CYTOMETRY PART A
- TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells
- (2011) Dat Q. Tran Journal of Molecular Cell Biology
- Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
- (2010) R. H. Prabhala et al. BLOOD
- TGF-β-related mechanisms of bone destruction in multiple myeloma
- (2010) Toshio Matsumoto et al. BONE
- Defective interleukin-2 induction of lymphokine-activatedkiller (LAK) activity in peripheral blood T lymphocytesof patients with monoclonal gammopathies
- (2010) M. MASSAIA et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Osteoclast synthesis and secretion and activation of latent transforming growth factor β
- (2010) Merry Jo Oursler JOURNAL OF BONE AND MINERAL RESEARCH
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started